Gene therapy strategies in prostate cancerEDER, Iris E; HAAG, Petra; BARTSCH, Georg et al.Current gene therapy. 2005, Vol 5, Num 1, pp 1-10, issn 1566-5232, 10 p.Article

Molecular biology of the androgen receptor: From molecular understanding to the clinicEDER, Iris E; CULIG, Zoran; PUTZ, Thomas et al.European urology. 2001, Vol 40, Num 3, pp 241-251, issn 0302-2838Article

Selective culture conditions for different types of primary human bladder cellsEDER, Iris E; CORVIN, Stefan; MANESCHG, Christoph et al.World journal of urology (Print). 2000, Vol 18, Num 5, pp 371-375, issn 0724-4983Article

Microbubble-enhanced ultrasound to deliver an antisense oligodeoxynucleotide targeting the human androgen receptor into prostate tumoursHAAG, Petra; FRAUSCHER, Ferdinand; GRADL, Johann et al.Journal of steroid biochemistry and molecular biology. 2006, Vol 102, Num 1-5, pp 103-113, issn 0960-0760, 11 p.Conference Paper

Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cellsPFEIL, Karina; EDER, Iris E; PUTZ, Thomas et al.The Prostate. 2004, Vol 58, Num 3, pp 259-268, issn 0270-4137, 10 p.Article

Antagonist/agonist balance of the nonsteroidal antiandrogen bicalutamide (Casodex) in a new prostate cancer modelHOBISCH, Alfred; HOFFMANN, Jens; LAMBRINIDIS, Leonidas et al.Urologia Internationalis. 2000, Vol 65, Num 2, pp 73-79, issn 0042-1138Article

Expression of androgen receptor coregulatory proteins in prostate cancer and stromal-cell culture modelsNESSLER-MENARDI, Claudia; JOTOVA, Iveta; CULIG, Zoran et al.The Prostate. 2000, Vol 45, Num 2, pp 124-131, issn 0270-4137Article